Beyond Deaths per Capita: Comparative CoViD-19 Mortality Indicators

Objectives Following well-established practices in demography, this article discusses several measures based on the number of CoViD-19 deaths to facilitate comparisons over time and across populations.

Settings National populations in 186 UN countries and territories and populations in first-level sub-national administrative entities in Brazil, China, Italy, Mexico, Peru, Spain, and the USA.

Participants None (death statistics only).

Primary and Secondary Outcome Measures An unstandardized occurrence/exposure rate comparable to the Crude Death Rate; an indirectly age-and-sex standardized rate that can be derived even when the breakdown of CoViD-19 deaths by age and sex required for direct standardization is unavailable; the reduction in life expectancy at birth corresponding to the 2020 number of CoViD-19 deaths.

Results To date, the highest unstandardized rate has been in New York, at its peak exceeding the state 2017 Crude Death Rate. Populations compare differently after standardization: while parts of Italy, Spain and the USA have the highest unstandardized rates, parts of Mexico and Peru have the highest standardized rates. For several populations with the necessary data by age and sex for direct standardization, we show that direct and indirect standardization yield similar results. US life expectancy is estimated to have declined this year by more than a year (−1.26 years), far more than during the worst year of the HIV epidemic, or the worst three years of the opioid crisis, and to reach its lowest level since 2008. Substantially larger reductions, exceeding two years, are estimated for Panama, Peru, and parts of Italy, Spain, the USA, and especially, Mexico.

Conclusions With lesser demand on data than direct standardization, indirect standardization is a valid alternative to adjust international comparisons for differences in population distribution by sex and age-groups. A number of populations have experienced reductions in 2020 life expectancies that are substantial by recent historical standards.

Strengths and limitations

• The CoViD-19 mortality indicators presented in this article are directly comparable with three well-established indicators of overall mortality: the Crude Death Rate, the Age-Standardized Death Rate and Life Expectancy at Birth

• In particular, this article demonstrates that when CoViD-19 deaths in a population are not tabulated by sex and age, indirect standardization techniques can still be used to improve comparisons of CoViD-19 mortality in this and other populations by accounting for differences in population distributions by age and sex

• While requiring additional data on mortality from other causes, translating cumulative numbers of CoViD-19 deaths into their impact on life expectancy at birth allows for comparison of CoViD-19 mortality with previous reversals in secular mortality declines

• The comparability of these CoViD-19 mortality indicators is affected by potential differences in identifying and reporting CoViD-19 as a cause of death across populations

• Further analyses are needed to assess potential changes in mortality from other causes induced by CoViD-19, as those would also contribute to the impact of CoViD-19 on life expectancy at birth